Cargando…

Correction: LRG1 as a novel therapeutic target in eye disease

Detalles Bibliográficos
Autores principales:	De Rossi, Giulia, Da Vitoria Lobo, Marlene E., Greenwood, John, Moss, Stephen E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170153/ https://www.ncbi.nlm.nih.gov/pubmed/35228692 http://dx.doi.org/10.1038/s41433-022-01988-6

Ejemplares similares

LRG1 as a novel therapeutic target in eye disease
por: De Rossi, Giulia, et al.
Publicado: (2022)

LRG1: an emerging player in disease pathogenesis
por: Camilli, Carlotta, et al.
Publicado: (2022)

Publisher Correction: Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway
por: Dritsoula, Athina, et al.
Publicado: (2022)

Structural basis of human LRG1 recognition by Magacizumab, a humanized monoclonal antibody with therapeutic potential
por: Gutiérrez-Fernández, Javier, et al.
Publicado: (2022)

Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target
por: Javaid, Faiza, et al.
Publicado: (2021)

LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration
por: Mundo, Lucia, et al.
Publicado: (2021)

Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway
por: Dritsoula, Athina, et al.
Publicado: (2022)

LRG1 promotes angiogenesis by modulating endothelial TGFß signalling
por: Wang, Xiaomeng, et al.
Publicado: (2013)

Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation
por: Yang, Jimin, et al.
Publicado: (2023)

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
por: Odeniyide, Patience, et al.
Publicado: (2022)

Environmental Triggers of lrgA Expression in Streptococcus mutans
por: Ishkov, Ivan P., et al.
Publicado: (2020)

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Modification of the Streptococcus mutans transcriptome by LrgAB and environmental stressors
por: Rice, Kelly C., et al.
Publicado: (2017)

Understanding LrgAB Regulation of Streptococcus mutans Metabolism
por: Ahn, Sang-Joon, et al.
Publicado: (2020)

Correction: Squalene Synthase As a Target for Chagas Disease Therapeutics
Publicado: (2014)

Author Correction: Diagnosis of colour vision deficits using eye movements
por: Taore, Aryaman, et al.
Publicado: (2022)

Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence
por: Hoefsmit, Esmee P., et al.
Publicado: (2023)

Regulation of cid and lrg expression by CodY in Streptococcus mutans
por: Ahn, Sang‐Joon, et al.
Publicado: (2020)

LRG1 is an adipokine that promotes insulin sensitivity and suppresses inflammation
por: Choi, Chan Hee J, et al.
Publicado: (2022)

LRG1 Associates with Iron Deficiency Anemia Markers in Adolescents
por: Alhammad, Rashed, et al.
Publicado: (2023)

Correction: Interleukin-6: a new therapeutic target
por: Smolen, Josef S, et al.
Publicado: (2006)

Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
por: Liu, Dongli, et al.
Publicado: (2022)

Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus
por: Vanninen, Aleksi, et al.
Publicado: (2021)

Characterization of LrgAB as a stationary phase-specific pyruvate uptake system in Streptococcus mutans
por: Ahn, Sang-Joon, et al.
Publicado: (2019)

Correction: Teprotumumab: A Review in Thyroid Eye Disease
por: Nie, Tina, et al.
Publicado: (2022)

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2009)

Correction to: Potential therapeutic targets for sarcopenia identified by Mendelian randomisation
Publicado: (2023)

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2015)

Remodeling of the Streptococcus mutans proteome in response to LrgAB and external stresses
por: Ahn, Sang-Joon, et al.
Publicado: (2017)

Correction: Novel Microglia-based Therapeutic Approaches to Neurodegenerative Disorders
por: Zhang, Lijuan, et al.
Publicado: (2023)

Correction: Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets
por: Paco, Sonia, et al.
Publicado: (2015)

Correction: Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets
por: Whitaker, John W., et al.
Publicado: (2015)

Correction to: Purinoceptor: a novel target for hypertension
por: Li, Xuan, et al.
Publicado: (2023)

Correction to: An ontological foundation for ocular phenotypes and rare eye diseases
por: Sergouniotis, Panagiotis I., et al.
Publicado: (2019)

Novel therapeutic strategies targeting mitochondria as a gateway in neurodegeneration
por: Trigo, Diogo, et al.
Publicado: (2022)

Correction to: Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Correction: Curcumin and Apigenin – novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease
Publicado: (2015)

Correction to: A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases
por: Gawel, Danuta R., et al.
Publicado: (2020)

Correction: Care for critically ill patients with COVID-19: don’t forget the eyes
por: Clough, N., et al.
Publicado: (2020)

Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
por: Greenwood, John, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_58iv5n94ssfj2qt6e46rl23ae5